Trial Details
RECRUITINGBasic Information
| Clinical ID | c927 |
|---|---|
| Identifier | NCT05205603 |
| Trial Title | Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Efficacy, Self|Biologics|Mesalazine |
| Interventions | DRUG: Infliximab|DRUG: Vedolizumab|DRUG: Mesalazine |
Participant Information
| Sponsor | Sixth Affiliated Hospital, Sun Yat-sen University |
|---|---|
| City | Chongqing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2022-01-15 |
|---|---|
| Primary Completion Date | 2024-01-15 |
| Completion Date | 2025-01-15 |